Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic...

Area of Science:

• Pediatric Hematology
• Bone Marrow Failure Syndromes
• Hematopathology

Background:

• Pediatric acquired aplastic anemia (AA) shares features with inherited bone marrow failure syndromes and hypocellular refractory cytopenia of childhood (RCC).
• Historically, hypocellular RCC has often been misdiagnosed as AA, complicating treatment and outcome assessment.

Purpose of the Study:

• To evaluate the clinical and histological distinctions between pediatric AA and RCC.
• To assess the reproducibility and clinical significance of the RCC classification in pediatric patients.

Main Methods:

• Retrospective analysis of 149 pediatric patients diagnosed with AA between 1976 and 2010.
• Evaluation of event-free survival (EFS), overall survival (OS), treatment response, toxicities, and clonal evolution.
• Reclassification of 72 diagnostic pathology specimens by three pediatric hematopathologists using 2008 WHO Criteria.

Main Results:

• Overall 5-year EFS was 50.8% and OS was 73.1%.
• Pathologist concordance in diagnosing AA versus RCC was modest.
• RCC showed a trend toward improved OS and EFS, without predicting immunosuppression therapy failure; clonal evolution was rare and linked to moderate AA.

Conclusions:

• The diagnosis of RCC in children is difficult to establish with certainty and its clinical significance is questionable.
• The reproducibility of the RCC classification is limited, necessitating further research to clarify its role in pediatric bone marrow failure.
• Accurate differentiation between AA and RCC is crucial for appropriate patient management and prognostic evaluation.